Ida Khodami

Ida Khodami is a Partner based in San Diego with expertise in genomics, biotech, and operations. Ida joined TBC from Illumina, where she held multiple leadership positions across engineering and operations for over a decade. She built and led the first company validation consortium that resulted in FDA approval for the first-ever Next Generation Sequencing platform: MiSeqDX. Over the past three years, she has led the global business strategy and operations for the direct-to-consumer genomics market. Ida earned her MS in Electrical Engineering and Computer Science from the University of Waterloo.